An Early Phase 1 interventional study of Personalized legal care services in Colorectal Cancer, sponsored by University of Minnesota. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.
Sponsored by University of Minnesota · Early Phase 1, Interventional, and Other
This is a single center single-arm, pilot study of proactive and early connection with free legal care services for persons with advanced colorectal cancer to assess the feasibility, acceptability, and preliminary efficacy of this intervention in improving financial and psychosocial outcomes. Participants will receive free, personalized legal care services from Cancer Legal Care (CLC), a nonprofit organization located in the Twin Cities of Minnesota. The duration of study participation is 6 months, however, participants may continue to access free personalized legal care services beyond this period. All participants continue to receive standard of care as prescribed by their treating physician.
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.
This study's enrollment of 20 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
adult patients with advanced colorectal cancel
Other: Personalized legal care services
Participants will receive free, personalized legal care services from Cancer Legal Care (CLC), a nonprofit organization located in the Twin Cities of Minnesota. The duration of study participation is 6 months, however, participants may continue to access free personalized legal care services beyond this period.
The Perceived Stress Scale 4 (PSS-4)
A 4-item measure of perceived stress.
Time frame: baseline, 3 months, 6 months
The Cancer Behavior Inventory-Brief Version (CBI-B)
A 12-item measure of self-efficacy coping with cancer.
Time frame: baseline, 3 months, 6 months
The COmprehensive Score for financial Toxicity (COST)
A 12-item measure of financial toxicity.
Time frame: baseline, 3 months, 6 months
The National Comprehensive Cancer Network's (NCCN) Distress Thermometer
A single-item measure of psychological distress.
Time frame: baseline, 3 months, 6 months
The Spitzer Uniscale (UNISCALE)
A single-item measure of overall quality of life.
Time frame: baseline, 3 months, 6 months
Patient Satisfaction with Interpersonal Relationship with Navigator (PSN-I)
A 9-item measure of perceptions of interpersonal relationships with a patient navigator (i.e. CLC).
Time frame: baseline, 3 months, 6 months
Pearlin Mastery Scale
A 7-item measure of psychological coping (mastery).
Time frame: baseline, 3 months, 6 months
The Life Engagement Test (LET)
A 6-item measure of purpose in life, defined as the extent to which a person engages in activities that are personally meaningful.
Time frame: baseline, 3 months, 6 months
Rosenberg Self-Esteem (RSE) Scale
A 10-item measure of self-esteem.
Time frame: baseline, 3 months, 6 months
Cancer Related Behavior Questionnaire
A 31-item measure of comfort facing cancer related issues.
Time frame: baseline, 3 months, 6 months
Cancer Legal Care Services Questionnaire
A 13-item measure of CLC
Time frame: baseline, 3 months, 6 months
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Minnesota